Senti Biosciences Holdings, Inc.
For the period ended May 14, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 14, 2026 · Filed May 14, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Operational and Financial Restructuring Progress
Operational and Financial Restructuring Progress
During the first quarter, Senti Bio completed amendments to its Alameda lease and related GeneFab sublease arrangements, significantly reducing future lease obligations and streamlining operations.
These actions contributed to a $6.9 million gain from lease modification during the quarter and are expected to further reduce the Company’s ongoing operating expense profile.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.